Enovis (ENOV) Notes Payables (2015 - 2016)
Enovis' (ENOV) quarterly Notes Payables came in at $151.0 million in Q4 2016, down 22.57% year-over-year from $195.0 million in Q1 2016, and down 22.57% quarter-over-quarter from $195.0 million in Q4 2015.
Powered by 
Analysis
Enovis (ENOV) Notes Payables (2015 - 2016) Analysis & Trends
Enovis (ENOV) has reported Notes Payables for 2 consecutive years, with $151.0 million the latest figure, recorded in Q4 2016.
- On a quarterly basis, Notes Payables fell 22.57% year-over-year to $151.0 million in Q4 2016; TTM through Dec 2016 was $151.0 million, a 22.57% decrease from a year earlier, with the FY2016 full-year figure at $151.0 million, down 22.57% from the prior year.
- Notes Payables was $151.0 million for Q4 2016 at Enovis, down from $195.0 million in the prior quarter.
- Over five years, Notes Payables peaked at $195.0 million in Q4 2015 and troughed at $151.0 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.56 Bn | 121.34 Bn | 1.96 Bn |
| 3 | Medtronic | 118.15 Bn | 109.33 Bn | 6.34 Bn |
| 4 | Stryker | 104.94 Bn | 101.46 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.07 Bn | 30.13 Bn | 830.00 Mn |
| 9 | Steris | 20.78 Bn | 20.29 Bn | 684.20 Mn |
| 10 | Enovis | 1.08 Bn | 1.07 Bn | 359.25 Mn |